Dr. Reddy's Laboratories collaborates with healthcare professionals, research institutions, and advocacy groups to foster partnerships and support initiatives aimed at improving patient care in the CNS therapeutic landscape, including participation in scientific conferences, advisory boards, patient treatment adherence programs and awareness campaigns.

We endeavour to provide the latest scientific advances in the field of neurology and psychiatry, that will enhance clinical knowledge in diagnosis, treatment and management, ultimately improving your patient's health and well-being. 

Dr. Reddy's Laboratories CNS portfolio includes medications for Schizophrenia, Bipolar Mood Disorders (BMD), Major Depressive Disorders (MDD), Attention Deficit Hyperactivity Disorder (ADHD), Epilepsy, Alzheimer’s disease and Diabetic Neuropathic pain (DPNP).